Veterinary Vaccines in the Development of Vaccination and Vaccinology

  • Philippe Desmettre
Chapter

Abstract

In 1796, Jenner, an English physician, performed the very first human immunization using an animal virus. Since he had noticed that dairy farmers infected with cowpox had become resistant to smallpox, he had the idea of inoculating the cowpox (or vaccinia) virus to protect humans against smallpox [1].

As a tribute to Jenner, Pasteur decided in 1881 to extend the meaning of the word vaccine to preventive inoculation with any type of infectious agent [2].

Keywords

Hepatitis Attenuation Tuberculosis Bacillus Microbe 

References

  1. 1.
    Jenner E. The Origin of the Vaccine Inoculation. London: Shury, Din Eds. 1801Google Scholar
  2. 2.
    Pasteur L. Des virus vaccins. Rev Sci 1881;8:225–8Google Scholar
  3. 3.
    Pasteur L. De l’atténuation du virus du cholera de poules. CR Acad Sci 1880;91:673–80Google Scholar
  4. 4.
    Pasteur L, Chamberland C, Roux E. Le vaccin du charbon. CR Acad Sci 1881;92:666–8Google Scholar
  5. 5.
    Chamberland C, Roux E. Sur l’atténuation de la virulence de la bactéridie charbonneuse sous I’influence des substances antiseptiques. CR Acad Sci 1883;96:1088–91, 1401–12Google Scholar
  6. 6.
    Pasteur L, Thuillier M. La vaccination du rouget des porcs à l’aide du virus mortel atténué de cette maladie. CR Acad Sci 1883;97:1163–9Google Scholar
  7. 7.
    Pasteur L, Chamberland C, Roux E, Thuillier M. Nouveaux faits pour sevir à la connaissance de la rage. CR Acad Sci 1882;95:1187–92Google Scholar
  8. 8.
    Galtier PV. Études sur la rage. CR Acad Sci 1879;89:444–6Google Scholar
  9. 9.
    Galtier PV. Les injections du virus rabique dans le torrent cicurlatoire ne provoquent pas l’éclosion de la rage et semblent conférer l’immunité. CR Acad Sci 1881;93:284–5Google Scholar
  10. 10.
    Pasteur L, Roux E, Chamberland C, Thuillier M. Sur la rage. CR Acad Sci 1881;92:1259–60Google Scholar
  11. 11.
    Pasteur L Chamberland C, Roux E. Sure la rage. CR Acad Sci 1884;98:1229–31Google Scholar
  12. 12.
    Pasteur L. Méthode pour prévenir la rage après morsure. CR Acad Sci 1885;101:765–74Google Scholar
  13. 13.
    Chauveau JB. Des causes qui peuvent faire varier les résultats de l’inoculation charbonneuse sur le moutons algérians. Influence de la quantité des agents infectants. Application à la théorie de l’immunité. CR Acad Sci 1880;90:1526–30Google Scholar
  14. 14.
    Behring E, Kitasato S. Über das Zustandekommen der Diphterieimmunität und der Tetanusimmunität bei Tieren. Dtsch Med Woch 1890;16:1113–4CrossRefGoogle Scholar
  15. 15.
    Salmon D, Smith T. One method of producing immunity from contagious diseases. Am J Vet Rev 1886;10:63–9Google Scholar
  16. 16.
    Roux E, Chamberland C. Immunité contre le septicemia conférée par des substances solubles. Ann Inst Pasteur 1887;1:561–74Google Scholar
  17. 17.
    Nocard E. Sur la sérothérpie du tetanus en vétérinaire. Bull Soc Cent Med Vet 1894; 12 (ns):723–9Google Scholar
  18. 18.
    Leclainche E, Vallée H. Sur la vaccination contre le charbon symptomatique pas les toxins. CR Acad Sci 1923;176:207–10Google Scholar
  19. 19.
    Ramon G. Sur le pouvoir floculant et sur les propriétés immunisantes d’une toxine diphtérique rendue anatoxique (anatoxine). CR Acad Sci 1923;177:1338–40Google Scholar
  20. 20.
    Ramon G. Des anatoxines. CR Acad Sci 1924;178:1436–9Google Scholar
  21. 21.
    Ramon G. Sur la production des antitoxins. CR Acad Sci 1925;181:157–9Google Scholar
  22. 22.
    Ramon G, Zoeller C. Les “vaccins associés” par union d’une anatoxine et d’un vaccin microbien (T.A.B.) ou par mélange d’anatoxines. CR Soc Biol. 1926;94:106–9Google Scholar
  23. 23.
    Calmette A, Guérin C. Sur quelques propriétés du bacilli tuberculeux d’origine bovine cultivé sur bile de bœuf glycérinée. CR Acad Sci 1909;150:716–8Google Scholar
  24. 24.
    Calmette A, Guérin C. Nouvelles recherches expérimentales sur la vaccination des bovidés contre la tuberculose et sur le sort du bacilli tuberculeux dans l’organisme de vaccinés. Ann Inst Pasteur 1931;27:162–9Google Scholar
  25. 25.
    Buck JM. Studies of vaccination during calfhood to prevent bovine infection abortion. J Agric Res 1930;43:667–89Google Scholar
  26. 26.
    Elberg S, Faunce K. Immunization against Brucella infection. VI. Immunity conferred on goats by non dependent mutat from a streptomycin-dependent mutant strain of Brucella melitensis. J Bacteriol 1957;73:211–7Google Scholar
  27. 27.
    McEwen A, Samuel J. Brucella abortus: heat stable, protective antigen revealed by adjuvant and present in a “rough” variant strain 45/20: immunization experiments on guinea pigs. Vet Rec 1955;67:546–8Google Scholar
  28. 28.
    Vallée H. Carré H, Rinjard P. Sur l’immunisation antiphteuse par le vaccin formolé. Rev Gen Med Vet 1926;35:129–34Google Scholar
  29. 29.
    Schmidt S. Die Bedeutung der Adsorption für die active Immunisierung gegen Viruskrankheiten. Arch Ges Virusforsch 1939;1:215–36CrossRefGoogle Scholar
  30. 30.
    Waldmann O, Pyl G, Hobohrn KO, Mohlmann H. Die Entwicklung des Riemse Adsorbatimpfstoffes gegen Maul- und Klauenseuche und seine Herstellung. Zentralbl Bakeriol I Orig 1941;148:1Google Scholar
  31. 31.
    Frenkel HS. La culture du virus de la fièrve aphteuse sur l’épithélium de la langue des bovidés. Bull OIE 1947;28:155–62Google Scholar
  32. 32.
    Girard HC, Macowiak C. La culture du virus aphteux au stade industriel. Rev immunol 1953;17:224–38Google Scholar
  33. 33.
    Capstick PB, Telling RC, Chapman WG, Stewart DL. Growth of a cloned strain of hamster kidney cells in suspended cultures and their susceptibility to the virus of foot-and-mouth disease. Nature 1962;195:1163–4PubMedCrossRefGoogle Scholar
  34. 34.
    Espinet RG. Nuevo tipo vacuna antiaftosa a complete glucovirico. Gac Vet 1951;13:265–77Google Scholar
  35. 35.
    Michel C, Terré J Soulebot JP, Desmettre P, Chappuis G, Stellmann C. Vaccination associée du chien, comparaison entre vaccinations successives et vaccinations simultanées. Bull Acad Vet 1971;43:277–84Google Scholar
  36. 36.
    Chappuis G. Terré J, Precausta P, Mougeot H, Moreau Y, Stellmann C. Vaccination associée du chien. Le vaccin pentavalent. Revue med Vet 1973;124:877–97Google Scholar
  37. 37.
    Davoust B, Muller G, Chappuis G. Vaccinations associées du chien: response sérologique à un vaccin hexavalent utilisé en rappel. Revue Med Vet 1985;136:363–72Google Scholar
  38. 38.
    Chappuis G, Benoit-Jeanin C, Fargeaud D. Rhinotrachéite feline: vaccin inactive, purifié et modèle expérimental. 17th International Congress on Herpesvirus of Man and Animal. Standardization of Immunological Procedures, Lyon, France. In: Develop Biol Stand 1981;52:485–91Google Scholar
  39. 39.
    Chappuis G, Fargeaud D, Brun A. Industrial production and control of a subunit vaccine against Aujeszky’s disease. In: Van Oirschot JT, ed. Vaccination and Control of Aujeeszky’s Disease. Dordrecht: Kluwer Academic Publishers, 1989Google Scholar
  40. 40.
    Fermi C. Über die Immunisierung gegen Wutkrankheit. Z Hyg Infekt Krankh 1908;58:233–76CrossRefGoogle Scholar
  41. 41.
    Semple D. The preparation of safe and efficient antirabies vaccine. Bull Inst Pasteur 1911;9:701Google Scholar
  42. 42.
    Fuenalida E, Palacios R. Rabies vaccine prepared from brains of infected suckling mice. Biol Inst Bacteriol 1955;8:3–10Google Scholar
  43. 43.
    Peck FB, Powel HM, Culbertson CG. Duck embryo rabies vaccine: study of fixed virus vaccine grown in embryonated duck eggs and killed with betapropiolactone. JAMA 1956;162:1373–6Google Scholar
  44. 44.
    Koprowski H, Cox H. Studies on chick embryo adapted rabies virus. J Immun 1948;60:533–54PubMedGoogle Scholar
  45. 45.
    Koprowski H, Black J. Studies on chick embryo adapted rabies virus. II. Pathogenicity for dogs and use of egg adapted stains for vaccination purposes. J Immun 1950;64:185–96Google Scholar
  46. 46.
    Koprowski H. Biological modification of rabies virus as a result of its adaptation to chicks and developing chick embryos. Bull WHO 1954;10:709–24PubMedGoogle Scholar
  47. 47.
    Abelseth MK. An attenuated rabies vaccine for domestic animals produced in tissue cultures. Can Vet J 1964;5:279–86PubMedGoogle Scholar
  48. 48.
    Fenje P. A rabies vaccine from hamster kidney tissue cultures: preparation and evaluation in animals. Can J Microbiol 1960;6:605–9PubMedCrossRefGoogle Scholar
  49. 49.
    Soulebot JP, Precausta P, Brun A et al. Prophlylaxie de la rage animale (ou vétérinaire) par un vaccin inactive monovalent ou associé. Dev Biol Stand 1978;41:389–99PubMedGoogle Scholar
  50. 50.
    Wiktor TJ, György E, Schlumberger HD, Sokol F, Koprowski H. Antigenic properties of rabies virus components. J Immun 1973;110:269–76PubMedGoogle Scholar
  51. 51.
    Kieny MP, Lathe R, Drillien R et al. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 1984;312:163–6PubMedCrossRefGoogle Scholar
  52. 52.
    Wiktor TJ, MacFarlan RI, Reagan KJ et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci USA 1984;81:7194–8PubMedCrossRefGoogle Scholar
  53. 53.
    Anilionis A, Wunner WH, Curtiss PJ. Structure of the glycoprotein gene in rabies virus. Nature 1981;294:275–8PubMedCrossRefGoogle Scholar
  54. 54.
    Blancou J, Kieny MP, Lathe R et al. Oral vaccination of the fox against rabies using recombinant vaccinia virus. Nature 1986;322:373–5PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Philippe Desmettre
    • 1
  1. 1.Rhône MérieuxLyonFrance

Personalised recommendations